If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
United States Prescribing Information - Trulicity® (dulaglutide) REWIND Study Label Updates [Video]
The REWIND cardiovascular outcomes trial provided important information used to update the Trulicity USPI. Dr. Sherry Martin will discuss these additions.
Date of Last Review: October 08, 2020
Document Number: VV-MED-93511